Page last updated: 2024-11-03

riluzole and Colorectal Cancer

riluzole has been researched along with Colorectal Cancer in 2 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Research Excerpts

ExcerptRelevanceReference
"We found that of the colorectal cancer-derived cell lines tested, HCT116 showed the highest mesenchymal profile and a high hERG1 expression."5.46The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells. ( Fortunato, A, 2017)
"We found that of the colorectal cancer-derived cell lines tested, HCT116 showed the highest mesenchymal profile and a high hERG1 expression."1.46The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells. ( Fortunato, A, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fortunato, A1
Pillozzi, S1
D'Amico, M1
Bartoli, G1
Gasparoli, L1
Petroni, G1
Crociani, O1
Marzo, T1
Guerriero, A1
Messori, L1
Severi, M1
Udisti, R1
Wulff, H1
Chandy, KG1
Becchetti, A1
Arcangeli, A1

Other Studies

2 other studies available for riluzole and Colorectal Cancer

ArticleYear
The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
    Cellular oncology (Dordrecht), 2017, Volume: 40, Issue:4

    Topics: Animals; Anticonvulsants; Antineoplastic Agents; Caco-2 Cells; Cell Line, Tumor; Cell Survival; Cisp

2017
The combined activation of K
    British journal of cancer, 2018, Volume: 118, Issue:2

    Topics: Animals; Apoptosis; Benzothiazoles; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Colorect

2018